Accéder au contenu
Merck

ADAM12 Is a Novel Regulator of Tumor Angiogenesis via STAT3 Signaling.

Molecular cancer research : MCR (2017-08-03)
Roopali Roy, Adelle Dagher, Catherine Butterfield, Marsha A Moses
RÉSUMÉ

ADAM12, (

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
AG 1478, A cell-permeable, reversible, ATP-competitive, highly potent and selective inhibitor of epidermal growth factor receptor kinase versus HER2-neu and platelet-derived growth factor receptor kinase.
Sigma-Aldrich
MISSION® esiRNA, targeting human EGFR
Sigma-Aldrich
MISSION® esiRNA, targeting human STAT3
Sigma-Aldrich
MISSION® esiRNA, targeting human ADAM12